Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001641172-25-025647
Filing Date
2025-08-27
Accepted
2025-08-27 09:15:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4998
  Complete submission text file 0001641172-25-025647.txt   6758
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Subject) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91021 | Film No.: 251260240
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 404 WASHINGTON AVE SUITE 650 MIAMI BEACH FL 33139
Business Address 404 WASHINGTON AVE SUITE 650 MIAMI BEACH FL 33139 786-381-2877
Lincoln Alternative Strategies LLC (Filed by) CIK: 0002043812 (see all company filings)

EIN.: 991727271 | State of Incorp.: DE | Fiscal Year End: 0324
Type: SCHEDULE 13G